Association of Serum Copeptin Levels with Patency of Infarct-Related Arteries in Patients with ST-Segment Elevation Myocardial Infarction

Doganay B., Okutucu S., Cetin M., Kiziltunc E., Karayigit O., Ozkan C., ...More

ACTA CARDIOLOGICA SINICA, vol.35, no.4, pp.360-368, 2019 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 4
  • Publication Date: 2019
  • Doi Number: 10.6515/acs.201907_35(4).20181101a
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.360-368
  • Gazi University Affiliated: Yes


Background: Copeptin is widely used as a predictor of an adverse prognosis in many clinical conditions. Reduced antegrade coronary flow in an infarct-related artery (IRA) is associated with adverse clinical outcomes in patients with ST-segment elevation myocardial infarction (STEMI). The aim of this study was to investigate whether copeptin level on admission was associated with IRA patency in STEMI patients.